These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8322486)

  • 21. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J; Raghavan S; Svennerholm AM
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.
    Tan Z; Liu W; Liu H; Li C; Zhang Y; Meng X; Tang T; Xi T; Xing Y
    Eur J Pharm Biopharm; 2017 Feb; 111():33-43. PubMed ID: 27865932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of BALB/c mice against experimental Helicobacter pylori infection by oral immunisation with H pylori heparan sulphate-binding proteins coupled to cholera toxin beta-subunit.
    Ruiz-Bustos E; Sierra-Beltran A; Romero MJ; Rodriguez-Jaramillo C; Ascencio F
    J Med Microbiol; 2000 Jun; 49(6):535-541. PubMed ID: 10847207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immunization against "Candidatus Helicobacter suis" with heterologous antigens of H. pylori and H. felis.
    Hellemans A; Decostere A; Duchateau L; De Bock M; Haesebrouck F; Ducatelle R
    Vaccine; 2006 Mar; 24(14):2469-76. PubMed ID: 16423431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study.
    Sutton P; Danon SJ; Walker M; Thompson LJ; Wilson J; Kosaka T; Lee A
    Gut; 2001 Oct; 49(4):467-73. PubMed ID: 11559641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immunization against Helicobacter stimulates long-term immunity.
    Radcliff FJ; Chen M; Lee A
    Vaccine; 1996 Jun; 14(8):780-4. PubMed ID: 8817825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
    Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
    Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.
    Gómez-Duarte OG; Lucas B; Yan ZX; Panthel K; Haas R; Meyer TF
    Vaccine; 1998 Mar; 16(5):460-71. PubMed ID: 9491500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens.
    Keenan JI; Rijpkema SG; Durrani Z; Roake JA
    FEMS Immunol Med Microbiol; 2003 May; 36(3):199-205. PubMed ID: 12738392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
    Ghasemi A; Mohammad N; Mautner J; Taghipour Karsabet M; Amani J; Ardjmand A; Vakili Z
    Vaccine; 2018 Aug; 36(34):5124-5132. PubMed ID: 30041879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunisation against gastric infection with Helicobacter species: first step in the prophylaxis of gastric cancer?
    Chen M; Lee A; Hazell S; Hu P; Li Y
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):155-65. PubMed ID: 8280938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice.
    Akhiani AA; Stensson A; Schön K; Lycke NY
    J Immunol; 2005 Jun; 174(12):8144-53. PubMed ID: 15944323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning.
    Corthésy-Theulaz I; Corthésy B; Bachmann D; Velin D; Kraehenbuhl JP
    Infect Immun; 2003 Apr; 71(4):2226-9. PubMed ID: 12654845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization against Helicobacter pylori--a future concept.
    Michetti P
    J Gastroenterol; 1998; 33 Suppl 10():66-8. PubMed ID: 9840022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
    J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.
    Vajdy M; Singh M; Ugozzoli M; Briones M; Soenawan E; Cuadra L; Kazzaz J; Ruggiero P; Peppoloni S; Norelli F; del Giudice G; O'Hagan D
    Immunology; 2003 Sep; 110(1):86-94. PubMed ID: 12941145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection Against
    Pan X; Ke H; Niu X; Li S; Lv J; Pan L
    Front Immunol; 2018; 9():1003. PubMed ID: 29867978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.